These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11739830)

  • 1. Metabolic correlates of levodopa response in Parkinson's disease.
    Feigin A; Fukuda M; Dhawan V; Przedborski S; Jackson-Lewis V; Mentis MJ; Moeller JR; Eidelberg D
    Neurology; 2001 Dec; 57(11):2083-8. PubMed ID: 11739830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in network activity with the progression of Parkinson's disease.
    Huang C; Tang C; Feigin A; Lesser M; Ma Y; Pourfar M; Dhawan V; Eidelberg D
    Brain; 2007 Jul; 130(Pt 7):1834-46. PubMed ID: 17470495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.
    Fukuda M; Mentis MJ; Ma Y; Dhawan V; Antonini A; Lang AE; Lozano AM; Hammerstad J; Lyons K; Koller WC; Moeller JR; Eidelberg D
    Brain; 2001 Aug; 124(Pt 8):1601-9. PubMed ID: 11459751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levodopa infusion on motor activation responses in Parkinson's disease.
    Feigin A; Ghilardi MF; Fukuda M; Mentis MJ; Dhawan V; Barnes A; Ghez CP; Eidelberg D
    Neurology; 2002 Jul; 59(2):220-6. PubMed ID: 12136061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M
    Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated PET/MRI With
    Wu Y; Xu XJ; Sun X; Zhai H; Wang T; Cao XB; Xu Y
    Behav Brain Res; 2023 Oct; 454():114609. PubMed ID: 37532003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network modulation in the treatment of Parkinson's disease.
    Asanuma K; Tang C; Ma Y; Dhawan V; Mattis P; Edwards C; Kaplitt MG; Feigin A; Eidelberg D
    Brain; 2006 Oct; 129(Pt 10):2667-78. PubMed ID: 16844713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging.
    Wu P; Wang J; Peng S; Ma Y; Zhang H; Guan Y; Zuo C
    Parkinsonism Relat Disord; 2013 Jun; 19(6):622-7. PubMed ID: 23529021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
    Hirato M; Ishihara J; Horikoshi S; Shibazaki T; Ohye C
    Acta Neurochir Suppl; 1995; 64():5-8. PubMed ID: 8748574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic correlates of metabolic network activity in Parkinson's disease.
    Holtbernd F; Ma Y; Peng S; Schwartz F; Timmermann L; Kracht L; Fink GR; Tang CC; Eidelberg D; Eggers C
    Hum Brain Mapp; 2015 Sep; 36(9):3575-85. PubMed ID: 26037537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
    Ma Y; Tang C; Spetsieris PG; Dhawan V; Eidelberg D
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):597-605. PubMed ID: 16804550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional impact of subthalamotomy by magnetic resonance-guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting-state brain metabolism.
    Rodriguez-Rojas R; Pineda-Pardo JA; Martinez-Fernandez R; Kogan RV; Sanchez-Catasus CA; Del Alamo M; Hernández F; García-Cañamaque L; Leenders KL; Obeso JA
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):425-436. PubMed ID: 31705173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
    Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S
    Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.
    Matthews DC; Lerman H; Lukic A; Andrews RD; Mirelman A; Wernick MN; Giladi N; Strother SC; Evans KC; Cedarbaum JM; Even-Sapir E
    Neuroimage Clin; 2018; 20():572-579. PubMed ID: 30186761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
    Goetz CG; Stebbins GT; Blasucci LM
    Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
    Berding G; Odin P; Brooks DJ; Nikkhah G; Matthies C; Peschel T; Shing M; Kolbe H; van Den Hoff J; Fricke H; Dengler R; Samii M; Knapp WH
    Mov Disord; 2001 Nov; 16(6):1014-22. PubMed ID: 11748732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.
    Mure H; Hirano S; Tang CC; Isaias IU; Antonini A; Ma Y; Dhawan V; Eidelberg D
    Neuroimage; 2011 Jan; 54(2):1244-53. PubMed ID: 20851193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease.
    Tomše P; Jensterle L; Rep S; Grmek M; Zaletel K; Eidelberg D; Dhawan V; Ma Y; Trošt M
    Phys Med; 2017 Sep; 41():129-135. PubMed ID: 28188080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts.
    Meles SK; Renken RJ; Pagani M; Teune LK; Arnaldi D; Morbelli S; Nobili F; van Laar T; Obeso JA; Rodríguez-Oroz MC; Leenders KL
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):437-450. PubMed ID: 31768600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease-related network topographies characterized with resting state functional MRI.
    Vo A; Sako W; Fujita K; Peng S; Mattis PJ; Skidmore FM; Ma Y; Uluğ AM; Eidelberg D
    Hum Brain Mapp; 2017 Feb; 38(2):617-630. PubMed ID: 27207613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.